Plate Nº 22 · recorded October 19, 2026
Science Policy & FundingReported finding
White House Move to Control NIH Grants Draws Fire From Senators, Scientists
The White House has moved to take control of NIH grant decisions, drawing objections from U.S. senators and scientists who fear politicized funding of biomedical research.
By Marcus Bennett3 min read554 words
In brief
- The White House has moved to seize control of NIH grant decisions, Science | AAAS reports.
- U.S. senators and scientists have objected to the shift in how NIH awards research funding.
- NIH is the largest public funder of biomedical research in the world.
- Key details, including the legal basis and scope of the change, remain unclear.
The White House has moved to take control of NIH grant decisions, and both senators and scientists are pushing back hard.
That is the core of a report published by Science, the news outlet of the American Association for the Advancement of Science (AAAS). The change concerns who holds the pen when the National Institutes of Health decides which research projects receive federal funding.
What changed?
Under long-standing practice, career scientists and expert review panels at NIH evaluate grant applications. Panels score proposals on scientific merit, and institute directors then award the money. The White House move, as Science reports, would pull those award decisions toward political appointees inside the administration.
For working researchers, the change touches the single most consequential moment in their professional lives: the funding decision. A grant pays salaries, keeps labs open, and sustains multi-year projects. Whoever controls that decision controls, in practice, the direction of biomedical research in the United States.
The shift covers the National Institutes of Health, the world's largest public funder of biomedical research, whose grants support tens of thousands of projects across universities and hospitals nationwide.
Why are senators objecting?
Members of the U.S. Senate have reacted with alarm, according to the report. Lawmakers oversee NIH through the appropriations process and view its grant-making as a scientific function that Congress has insulated from political interference.
Senators worry the move sets a precedent: if the executive branch can redirect NIH award decisions, the same lever could apply to other federal science agencies. Their objections, as Science describes them, center on the loss of an independent, merit-based review system that Congress helped build.
The takeaway: legislators see this as a separation-of-powers question, not a bureaucratic reshuffle.
Why are scientists upset?
Researchers interviewed by Science expressed concern that political control over awards would distort what gets studied. Peer review, whatever its flaws, ranks ideas by evidence. A politically guided process, scientists argue, could favor some topics and starve others — basic research in particular, which rarely delivers quick, headline-friendly results.
Universities and scientific societies have echoed that concern. Their fear is concrete: labs that depend on renewals could wind down, and junior researchers, who need grants to establish themselves, may leave the field.
In plain words, scientists see the move as a threat to the integrity of the process that decides which medical questions get answered.
How firm is the picture?
Caveats matter here. The report describes a developing situation. Key details remain unclear at this stage, including:
- Exactly which grant decisions would move to White House control;
- Whether the change applies to new awards, renewals, or both;
- What legal authority the administration claims for the shift;
- Whether Congress can block or reverse it.
Neither the White House nor NIH leadership has fully settled those questions publicly, based on the information available. Readers should treat the specifics as preliminary and expect updates.
What happens next?
Watch three things: any formal response from Senate committees that oversee NIH, statements from universities and scientific societies, and the first funding decisions made under the new arrangement. Those decisions will show whether the change alters outcomes in practice or remains, for now, a contested assertion of authority.
The fight over NIH grants is, at bottom, a fight over who decides what American science studies.
via Google News: Science Funding (Source)
More from Marcus Bennett
Show full bio
News editor covering regulation, policy and their impact on general science news at SciBeat.
263 articles
Nearby plates
- White House Moves to Take Control of N.I.H. Grants
- White House Retreats From Plan to Tighten Grip on N.I.H. Grants
- White House Proposal Would Give Political Appointees Final Say on Research Grants
- Trump Administration Seeks More Political Control Over Science Grants
- White House Redirects Science Funding Toward AI and Individual Researchers